| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049431388 |
| P356 | DOI | 10.1186/1465-9921-12-128 |
| P932 | PMC publication ID | 3193170 |
| P698 | PubMed publication ID | 21951574 |
| P5875 | ResearchGate publication ID | 51666423 |
| P50 | author | Steeve Provencher | Q92750879 |
| P2093 | author name string | Audrey Courboulin | |
| Jolyane Meloche | |||
| Roxane Paulin | |||
| Sébastien Bonnet | |||
| Malik Bisserier | |||
| Marjorie Barrier | |||
| Caroline Lambert | |||
| Maria Helena Jacob | |||
| Mathilde Chapolard | |||
| Véronique L Tremblay | |||
| P2860 | cites work | KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia | Q24314374 |
| MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation | Q24650539 | ||
| Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway | Q28115005 | ||
| Regulation of platelet-derived growth factor-A chain by Krüppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB | Q28211932 | ||
| Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling | Q28213257 | ||
| Significance of the transcription factor KLF5 in cardiovascular remodeling | Q28267393 | ||
| A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth | Q28283339 | ||
| The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted | Q28567772 | ||
| An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension | Q28576675 | ||
| STATs and gene regulation | Q29547796 | ||
| Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". | Q33145918 | ||
| Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension | Q33329056 | ||
| Perfusion of veins at arterial pressure increases the expression of KLF5 and cell cycle genes in smooth muscle cells | Q33670426 | ||
| Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension | Q33831900 | ||
| Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling | Q33930863 | ||
| Reversal of experimental pulmonary hypertension by PDGF inhibition | Q34048479 | ||
| Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline | Q34095444 | ||
| KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells | Q34477034 | ||
| Role for miR-204 in human pulmonary arterial hypertension | Q34681312 | ||
| Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation | Q35112792 | ||
| JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases | Q36306876 | ||
| The myocardial JAK/STAT pathway: from protection to failure | Q37266843 | ||
| KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization | Q37285044 | ||
| Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. | Q37350177 | ||
| Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques. | Q37406383 | ||
| Molecular mechanisms of pulmonary hypertension | Q37441315 | ||
| Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases | Q37486142 | ||
| A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension | Q37702950 | ||
| Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension | Q37703654 | ||
| Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells | Q39821441 | ||
| Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. | Q39834991 | ||
| Kruppel-like factor 5 is required for perinatal lung morphogenesis and function | Q39965475 | ||
| Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. | Q40359097 | ||
| KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line | Q40368983 | ||
| Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells | Q40421753 | ||
| An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension | Q41123021 | ||
| Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene | Q42440266 | ||
| Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension | Q42641623 | ||
| Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension | Q42737164 | ||
| Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. | Q42809184 | ||
| Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis | Q43276878 | ||
| Imatinib for the treatment of pulmonary arterial hypertension | Q46726764 | ||
| Endothelin receptor antagonists in pulmonary arterial hypertension | Q46779867 | ||
| The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation | Q46979783 | ||
| Inhibition of monocyte chemoattractant protein-1 by Krüppel-like factor 5 small interfering RNA in the tumor necrosis factor- alpha-activated human umbilical vein endothelial cells | Q47422549 | ||
| Smooth muscle cell outgrowth from coronary atherectomy specimens in vitro is associated with less time to restenosis and expression of a key Transcription factor KLF5/BTEB2. | Q47444169 | ||
| Endothelin-1 is elevated in monocrotaline pulmonary hypertension. | Q51476392 | ||
| Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. | Q53307573 | ||
| Survivin gene expression in chronic liver disease and hepatocellular carcinoma. | Q53500223 | ||
| Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? | Q54299949 | ||
| Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation | Q80385009 | ||
| Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours | Q81275952 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 128 | |
| P577 | publication date | 2011-09-27 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension | |
| P478 | volume | 12 |
| Q34907148 | BTEB2 prevents neuronal apoptosis via promoting bad phosphorylation in rat intracerebral hemorrhage model |
| Q47741857 | Beneficial effects of bile acid receptor agonists in pulmonary disease models |
| Q38438856 | Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension |
| Q58273930 | Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension |
| Q48338437 | Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). |
| Q37186961 | Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. |
| Q40972077 | HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension |
| Q50628390 | Increased pulmonary vascular expression of Krüppel-like factor 5 and activated survivin in experimental congenital diaphragmatic hernia. |
| Q33898213 | Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension |
| Q42765706 | Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice |
| Q53804088 | KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension. |
| Q38768833 | Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses. |
| Q38031130 | Kruppel-like factors and vascular inflammation: implications for atherosclerosis |
| Q49828837 | Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential |
| Q47676828 | Krüppel-like factors and vascular wall homeostasis. |
| Q93140689 | Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension |
| Q35183931 | Loss of Krüppel-like factor 6 cripples podocyte mitochondrial function |
| Q90260807 | Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics |
| Q28067063 | Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension |
| Q38676413 | Molecular pathogenesis and current pathology of pulmonary hypertension |
| Q24634317 | Molecular pathogenesis of pulmonary arterial hypertension |
| Q92198340 | Notch3 signalling and vascular remodelling in pulmonary arterial hypertension |
| Q42679024 | Overexpressed microRNA-506 and microRNA-124 alleviate H2O2-induced human cardiomyocyte dysfunction by targeting krüppel-like factor 4/5. |
| Q58792253 | Overexpression of KLF5 inhibits puromycin‑induced apoptosis of podocytes |
| Q36481412 | Possible role of Krüppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease |
| Q36545576 | Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. |
| Q92106557 | Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome |
| Q91705758 | Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling |
| Q46277870 | Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. |
| Q38140894 | STAT3 signaling in pulmonary arterial hypertension |
| Q37133785 | Signal transduction in the development of pulmonary arterial hypertension |
| Q51651690 | The Critical Role of Dynamin-Related Protein 1 in Hypoxia-Induced Pulmonary Vascular Angiogenesis. |
| Q27022848 | The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation |
| Q39353707 | The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies |
| Q37555457 | Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series). |
| Q38227557 | Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series). |
| Q53767909 | [Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications]. |
| Q47634134 | miR-200c regulates endothelin-1 induced PASMCs abnormal proliferation and apoptosis. |
| Q51290554 | miR-29a regulates vascular neointimal hyperplasia by targeting YY1. |
| Q38668258 | microRNA and Pulmonary Hypertension |
Search more.